Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
16.76
-0.05 (-0.30%)
At close: Apr 28, 2026, 4:00 PM EDT
16.99
+0.23 (1.37%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Theravance Biopharma Market Cap
Theravance Biopharma has a market cap or net worth of $863.02 million as of April 28, 2026. Its market cap has increased by 107.91% in one year.
Market Cap
863.02M
Enterprise Value
579.24M
1-Year Change
107.91%
Ranking
Category
Stock Price
$16.76
Market Cap Chart
Since May 16, 2014, Theravance Biopharma's market cap has increased from $740.70M to $863.02M, an increase of 16.51%. That is a compound annual growth rate of 1.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 865.60M | -8.70% |
| Dec 31, 2025 | 948.10M | 104.91% |
| Dec 31, 2024 | 462.70M | -17.33% |
| Dec 29, 2023 | 559.70M | -25.95% |
| Dec 30, 2022 | 755.80M | -7.20% |
| Dec 31, 2021 | 814.40M | -28.37% |
| Dec 31, 2020 | 1.14B | -22.64% |
| Dec 31, 2019 | 1.47B | 3.64% |
| Dec 31, 2018 | 1.42B | -6.02% |
| Dec 29, 2017 | 1.51B | -8.88% |
| Dec 30, 2016 | 1.66B | 166.99% |
| Dec 31, 2015 | 620.20M | 28.99% |
| Dec 31, 2014 | 480.80M | -35.09% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Phathom Pharmaceuticals | 899.94M |
| LB Pharmaceuticals | 899.84M |
| CytomX Therapeutics | 896.90M |
| Xencor | 891.06M |
| Janux Therapeutics | 882.06M |
| SELLAS Life Sciences Group | 876.36M |
| MannKind | 861.54M |
| Tenax Therapeutics | 859.62M |